[ii] ICH Harmonised Tripartite Guideline, Guidance for Industry, E6 (R1) Guideline for Good Clinical Practice [iii] Friends of Cancer Research. Randomized and Single-Arm Trials. [iv] Getz, Ken.

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the appointment of Babar Ghias as chief financial officer (CFO) ...

In fact, we recently conducted a study which found 62% of healthcare and life sciences execs have already moved GenAI use cases into production, with 74% seeing ROI from their GenAI investments on ...

A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on ...

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...

A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on ...

Clinical trial design is a key aspect of the successful conduct of clinical trials. It involves deciding parameters such as the number of patients, the length of the trial, the comparator arm (in ...

The platform's patient-focused outreach is beneficial in navigating the complexities of evolving eligibility criteria for ...

The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

In an interview with Fortune, Isomorphic Labs president Colin Murdoch shared that four years after its founding, the company ...

Latest Research and Reviews Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial ...